BG
HPTX

BlackRock Group’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

BlackRock Group’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,480
Closed -$68K – 3005
2015
Q1 		$68K Sell
1,480
-8,449
-85% -$253K ﹤0.01% 2731
2014
Q4 		$238K Buy
+9,929
New +$224K ﹤0.01% 2465

BlackRock Group's HPTX Position: Q2 2015 in Review

BlackRock Group sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 1,480 shares — an estimated $68K sold.

BlackRock Group first reported a position in HPTX in Q4 2014 and held it in 2 quarters. The position peaked at $238K in Q4 2014. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • BlackRock Group reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • BlackRock Group sold 1,480 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $68K.
  • BlackRock Group first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • BlackRock Group's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $238K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on BlackRock Group's 13F filing for Q2 2015, filed 7 Aug 2015.